7-aminoactinomycin d has been researched along with MS (Multiple Sclerosis) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borazanci, A; Gan, Y; Shi, FD; Shi, SX; Su, N; Zhu, X | 1 |
| Boselli, D; Clerico, M; Contessa, G; Conti, L; Durelli, L; Eid, P; Ferrero, B; Novelli, F; Ripellino, P | 1 |
2 other study(ies) available for 7-aminoactinomycin d and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Topics: Analysis of Variance; Annexin A5; Apoptosis; Bromodeoxyuridine; CD56 Antigen; Cell Proliferation; Cells, Cultured; Cytotoxicity, Immunologic; Dactinomycin; Female; Flow Cytometry; Humans; Interleukin-7; Interleukin-7 Receptor alpha Subunit; Killer Cells, Natural; Male; Multiple Sclerosis | 2014 |
T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
Topics: Adult; Annexin A5; Antigens, CD; Apoptosis; Cell Differentiation; Chi-Square Distribution; Dactinomycin; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation; Humans; Immunologic Factors; Interferon-beta; Interleukin-17; Leukocytes, Mononuclear; Male; Multiple Sclerosis; Receptor, Interferon alpha-beta; T-Lymphocytes, Helper-Inducer; Time Factors | 2009 |